Definitive Contract VA26816C0047
Award Date 5/10/16
Potential Completion Date 5/9/19
Potential Value $300K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organix Chemistry Solutions LLC was awarded a $3.677 million delivery order against the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences' CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract. The delivery order, issued for the period of September 28, 2020 through September 27, 2022, provides synthetic chemistry support services to the TDB Medicinal Chemistry Team. Key services will involve...
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
- This is a federal contract award to Aapharmasyn LLC, a small disadvantaged business, for Experimental Therapeutics Medicinal Chemistry services. The contract was awarded by the Defense Health Agency, a component of the U.S. Department of Defense, with a ceiling value of $77,780.00. The contract has a firm fixed price pricing type and was awarded as a delivery order under the Experimental Therapeutics Medicinal Chemistry contract vehicle. The contract does not have a set-aside designation. The...
- This federal contract award is for CHEMO COMPOUNDING SERVICES with a period of performance through September 30, 2025. The $674,796.03 firm fixed-price delivery order was awarded on December 11, 2023 to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The award is not set-aside and represents a specialized pharmaceutical compounding services contract focused on providing customized...
- This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
- <p>This is a firm fixed-price purchase order awarded by the Office of Naval Research (ONR), a defense agency, to Biogx, Inc., a for-profit manufacturer, for the delivery of chemicals. The contract has a ceiling value of $24,826.00 and a completion date of October 3, 2018. There is no set-aside designation mentioned for this award. The contract does not appear to be associated with a larger federal contract vehicle.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency of the U.S. government, to Polyorg, Inc., a for-profit manufacturer of specialized chemicals. The $7,250 contract is for the procurement of chemicals to support NICHD's biomedical research, with a performance period ending on September 30, 2017. The contract does not have a set-aside designation. Based on Polyorg's prior federal contract history,...
- This federal contract award, valued at $14,760.00, was issued by the Department of Health and Human Services (HHS) to American Biochemicals Inc., a minority-owned small disadvantaged business, for the custom synthesis and purification of the organic compound (2,2-DIMETHYL-2H-CHROMEN-5-YL) METHANOL. The contract was issued on a firm fixed-price basis and does not utilize a set-aside designation. American Biochemicals Inc. has previously provided specialized synthesis services to HHS agencies,...
- This federal contract award is for a delivery order under the "Ordering Period 4 - Sterile Compounding" contract, with a ceiling value of $100,000.00. The contract was awarded to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, on October 2, 2025. The contract is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network (VISN) 16, which is part of the U.S. Department of Veterans Affairs (VA). The contract involves the provision of...